Fields Heidi
- SEC CIK
- 0001014330
No open-market purchases or sales filed in the past year.
Current role at each company
- PHAT Phathom Pharmaceuticals, Inc.Directoras of May 21, 2026
- A Agilent Technologies, Inc.Directoras of Mar 18, 2025
- CIK 0001786255Other: See Remarksas of Feb 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Fields Heidi as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
A Agilent Technologies, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 (view filing) | Mar 5 | 2 days | Fields HeidiDirector | SSale | −1.66K | $144.34 | −$239.3K | −2.9%55.0K after | |
| Nov 28, 2022 (view filing) | Nov 23 | 5 days | Fields HeidiDirector | SSale | −3.63K | $155.84 | −$566.5K | −6.3%54.5K after |